1. Cystatin C predicts incident diabetes in angiographied coronary patients. (August 2022) Authors: Mader, A.; Sprenger, L.; Vonbank, A.; Larcher, B.; Maechler, M.; Grabher, V.; Leiherer, A.; Muendlein, A.; Drexel, H.; Saely, C.H. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Remnant cholesterol in patients with established cardiovascular disease predicts cardiovascular events both among patients with type 2 diabetes and among non-diabetic subjects. (August 2022) Authors: Mader, A.; Sprenger, L.; Vonbank, A.; Larcher, B.; Maechler, M.; Grabher, V.; Leiherer, A.; Muendlein, A.; Drexel, H.; Saely, C.H. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The ceramide- and phosphatidylcholine- based coronary event risk test2 (CERT2) and cardiovascular mortality in men and women with type 2 diabetes. (August 2022) Authors: Leiherer, A.; Muendlein, A.; Saely, C.H.; Larcher, B.; Mader, A.; Maechler, M.; Sprenger, L.; Grabher, V.; Laaksonen, R.; Laaperi, M.; Jylha, A.; Fraunberger, P.; Drexel, H. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The new myokine myonectin is significantly associated with type 2 diabetes in elderly cardiovascular disease patients. (August 2022) Authors: Leiherer, A.; Muendlein, A.; Geiger, K.; Saely, C.H.; Grabher, V.; Fraunberger, P.; Drexel, H. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Type 2 diabetes and risk of major cardiovascular events in peripheral artery disease versus coronary artery disease patients. (August 2022) Authors: Saely, C.H.; Vonbank, A.; Larcher, B.; Mader, A.; Maechler, M.; Sprenger, L.; Grabher, V.; Leiherer, A.; Muendlein, A.; Drexel, H. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Type 2 diabetes significantly modulates the power of lipoprotein(a) to predict cardiovascular events and mortality in young coronary artery disease patients. (August 2022) Authors: Mader, A.; Maechler, M.; Larcher, B.; Sprenger, L.; Grabher, V.; Leiherer, A.; Muendlein, A.; Vonbank, A.; Drexel, H.; Saely, C.H. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗